Production & Manufacturing
Manufacturing

Manufacturing News

View news from other Pharmaceutical sectors:
1-15 of 2327 results
Dermavant to buy rights to tapinarof from GSK for £250m
GSK announced that Dermavant Sciences, a subsidiary of Roivant Sciences, has agreed to purchase the rights to tapinarof, an investigational therapeutic aryl hydrocarbon receptor modulating agent (TAMA) for the treatment of psoriasis and atopic dermatitis and back-up programmes for a total consideration of £250m.
Production & Manufacturing > Manufacturing > News
US FTC approves Takeda’s $62bn acquisition of Shire
By PBR Staff Writer
Takeda Pharmaceutical’s £45.3bn ($62bn) acquisition of Shire has been unconditionally approved by the US Federal Trade Commission (FTC).
Production & Manufacturing > Manufacturing > News
Abzena signs manufacturing and bioconjugation deal with Telix
UK-based life sciences group Abzena has signed GMP manufacturing and bioconjugation agreements with Australia-based Telix Pharmaceuticals.
Production & Manufacturing > Manufacturing > News
CVC-led consortium to buy majority stake in Recordati for EUR3.03bn
By PBR Staff Writer
Private equity firm CVC Capital Partners-led consortium has agreed to acquire controlling stake in Italian drugmaker, Recordati, in a deal valued at €3.03bn.
Production & Manufacturing > Manufacturing > News
Sanofi, Advent finalize negotiations for acquisition of Zentiva
Sanofi and Advent International have completed negotiations for the acquisition of Zentiva, Sanofi’s European generics business, by Advent and the companies have signed a Share Purchase Agreement worth €1.9bn (enterprise value).
Production & Manufacturing > Manufacturing > News
Starpharma licenses VivaGel BV to Mundipharma for Europe
Starpharma and Mundipharma have signed a licence agreement for the sales and marketing rights to VivaGel BV for 43 countries in Europe, Russia, the Commonwealth of Independent States (CIS) and the balance of countries in Latin America.
Production & Manufacturing > Manufacturing > News
Novacap to acquire US-based CDMO PCI Synthesis
Novacap has agreed to acquire Boston-based PCI Synthesis, a pharmaceutical contract development and manufacturing organization (CDMO), for an undisclosed price.
Production & Manufacturing > Manufacturing > News
Beactica signs three-year extension of master services deal with Sanofi
Swedish drug discovery company Beactica has entered into a three-year extension of its master services agreement with Sanofi.
Production & Manufacturing > Manufacturing > News
Takeda to sell Techpool to Chinese JV partners
Takeda Pharmaceutical has agreed to divest its its majority shareholding of 51.34% in Guangdong Techpool Bio-Pharma (Techpool), a China-based firm focused on urinary protein biopharmaceuticals and production of biopharmaceuticals in critical care, to its joint venture (JV) partners for $280m.
Production & Manufacturing > Manufacturing > News
WuXi Biologics to establish $60m biologics manufacturing facility in Singapore
By PBR Staff Writer
Chinese firm WuXi Biologics has announced a S$80m ($60m) investment to set up an a biologics manufacturing facility in Singapore.
Production & Manufacturing > Manufacturing > News
Aquestive settles Suboxone drug patent infringement case with Par Pharmaceuticals
Aquestive Therapeutics has reached a settlement agreement resolving patent litigation related to Suboxone (buprenorphine and naloxone) Sublingual Film with Par Pharmaceuticals.
Production & Manufacturing > Manufacturing > News
Amryt, Aegerion sign expanded deal for Lojuxta capsules
Amryt has signed an agreement with Aegerion Pharmaceuticals to expand its exclusive licence agreement for Lojuxta (lomitapide) into Russia and the Commonwealth of Independent States (CIS), as well as the non-EU Balkan states.
Production & Manufacturing > Manufacturing > News
Takeda agrees to acquire Shire for £45.3bn
By PBR Staff Writer
Takeda Pharmaceutical has agreed to acquire Ireland-based rare disease biotech company Shire in a cash-cum stock deal worth around £45.3bn.
Production & Manufacturing > Manufacturing > News
Endo to buy Somerset Therapeutics for $190m
Endo International has agreed to acquire New Jersey-based Somerset Therapeutics, that develops and markets sterile injectable and ophthalmic drugs, and the business of its India-based affiliate Wintac, which operates as Somerset's contract developer and manufacturer.
Production & Manufacturing > Manufacturing > News
Shire considers Takeda's revised £46bn takeover offer
By PBR Staff Writer
Shire’s board said that it is willing to recommend Takeda Pharmaceutical’s revised acquisition offer of £46bn to its shareholders.
Production & Manufacturing > Manufacturing > News
1-15 of 2327 results